Efficacy and Safety of Newly Diagnosed Multiple Myeloma Combination Therapies: A Systematic Review Integrating Network Meta-Analysis and Real-World Vigilance Study.

Yanjun Liu, Ying Zhang, Wenhui Yang, Haoyan Du, Shijie Sun, Zuojing Li, Dongsheng Zong

Abstract readReview

In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanjun LiuSchool of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0009-0009-5347-1205

Ying ZhangNational Medical Products Administration, Beijing 100037, China.

Wenhui YangSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.

Haoyan DuSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.

Shijie SunSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.

Zuojing LiSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.

Dongsheng ZongSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.

Funding

Shijie Sun LJ112410163013

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse drug eventsdaratumumabFAERS databasemultiple myelomanetwork meta-analysis

Identifiers

PMID41599619

DOI10.3390/ph19010018

PMCPMC12845409

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.